Harnessing nanomedicine for mucosal theranostics--a silver bullet at last?
Level V
Where this comes from
- Record sourced from PubMed, PMID 23570555.
- Also identified by DOI 10.1021/nn400885b.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inflammatory bowel disease (IBD) has been extensively studied in the last four decades both in animal models and humans. The treatment options remain disappointing, nonspecific, and associated with multiple systemic adverse effects. In this Perspective, we highlight issues related to emerging nanotechnologies designed particularly for treatment and disease management of IBD and discuss potential therapeutic target options with novel molecular imaging modalities.
Medical subject headings
- Inflammatory Bowel Diseases
- Intestinal Mucosa
- Molecular Imaging
- Nanomedicine
- Nanoparticles